2021
DOI: 10.1161/circgen.120.003234
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1–Induced Pluripotent Stem Cell–Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome

Abstract: Background - Prior epidemiological studies demonstrated that the p.D85N-KCNE1 common variant reduces repolarization reserve and predisposes to drug-induced QT prolongation/torsades de pointes. We sought to develop a cellular model for drug-induced long QT syndrome (DI-LQTS) using a patient-specific induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM). Methods - p.D85N-KCNE1 iPSCs were generated from a 23-year-old female with an exaggerated QTc … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 25 publications
(50 reference statements)
0
1
0
Order By: Relevance
“…For our here investigated LQT5 mutations, too little clinical data on affected patients are available to conclusively determine whether the specific mutations cause sex differences in QT duration and arrhythmias or even estrous cycle–dependent changes in arrhythmic risk. However, for the common KCNE1 polymorphism pD85N, a sex-specific modulatory effect of the susceptibility to drug-induced LQTS has already been described with 17β-E2–mediated exaggeration of dofetilide-induced APD prolongation and increase in proarrhythmic early afterdepolarizations in induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) ( 51 ), pointing toward a normal WT-like inhibitory 17β-E2 effect on Kv7.1/KCNE1_D85N and strongly supporting a role of KCNE1 variants in mediating (parts of) the observed sex differences in LQTS.…”
Section: Discussionmentioning
confidence: 99%
“…For our here investigated LQT5 mutations, too little clinical data on affected patients are available to conclusively determine whether the specific mutations cause sex differences in QT duration and arrhythmias or even estrous cycle–dependent changes in arrhythmic risk. However, for the common KCNE1 polymorphism pD85N, a sex-specific modulatory effect of the susceptibility to drug-induced LQTS has already been described with 17β-E2–mediated exaggeration of dofetilide-induced APD prolongation and increase in proarrhythmic early afterdepolarizations in induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) ( 51 ), pointing toward a normal WT-like inhibitory 17β-E2 effect on Kv7.1/KCNE1_D85N and strongly supporting a role of KCNE1 variants in mediating (parts of) the observed sex differences in LQTS.…”
Section: Discussionmentioning
confidence: 99%